Ultima-CJC1295 2mg

MANUFACTURER Ultima Pharmaceuticals - USA
WAREHOUSE USA Warehouse 5
SUBSTANCE GHRH Peptide

Introducing CJC-1295, a cutting-edge synthetic analogue of growth hormone-releasing hormone (GHRH), composed of 30 amino acids. This powerful peptide has been clinically shown to significantly enhance growth hormone secretion and elevate IGF-1 levels while maintaining the natural pulsatility of GH release.

When combined with Ipamorelin, known for its targeted GHRH action, CJC-1295 provides an optimal approach to increasing growth hormone levels without the unwanted side effects typical of other peptides. Ipamorelin effectively raises growth hormone without stimulating appetite or elevating cortisol, acetylcholine, prolactin, or aldosterone. It is well-tolerated and works synergistically with CJC-1295 for superior results.

CJC-1295 also encourages deep, restorative slow-wave sleep, essential for optimal muscle growth, memory consolidation, and overall rejuvenation.

Produced in the hypothalamus, GHRH is released in pulses that stimulate the pituitary gland to secrete growth hormone. With a very short half-life of just a few minutes, the active portion of GHRH?the first 29 amino acids?is synthesized as Sermorelin, which has been modified for a longer half-life of 30 minutes. CJC-1295 takes it a step further by incorporating a Drug Affinity Complex (DAC) that binds to blood protein albumin, extending its half-life to an impressive 8 days. The non-DAC version of CJC-1295 mimics a more natural GH spike occurring nightly.

Thanks to the prolonged half-life facilitated by DAC, injections are only required once or twice a week. However, this stable blood level may lead to continuous stimulation for GH release from the pituitary via the GHRH receptor, which can diminish the physiological GH pulse amplitude and potentially lessen GH tissue stimulation over time.

To ensure optimal results, consider taking 'hormone holidays' of three months every three to six months while using long-acting CJC-1295. This allows the pituitary gland to recover. During these breaks, Sermorelin can serve as an effective alternative to CJC-1295 + DAC.

These 'hormone holidays' can also help mitigate the risk of developing GH resistance, which, while theoretical, could arise from antibody formation that deactivates GH or receptor down-regulation in tissues. So far, no long-term studies have definitively explored these concerns.

- Possible injection site reactions (such as irritation, redness, swelling, pain, itching) - Headaches - Diarrhea - Vasodilation (flushing, warmth, temporary low blood pressure) - Nausea - Abdominal discomfort.